BioCheetah Pte Ltd was honored to present the discovery and development journey of our VECanDx™ ELISA bladder cancer diagnostic test to Minister Tan See Leng. As an A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) spin-off company, we are proud to be part of the 40th anniversary celebration of IMCB. We look forward to the R&D translation of VECanDx™ ELISA diagnostic deployed in Singapore and beyond soon! Jean-Paul Thiery Kian-Chung Lee Dr. Ervinna Pang, PhD, CVA #BioCheetah #VECanDx #BladderCancer #Diagnostics #ASTAR #SingaporeBiotech #HealthcareInnovation #TranslationalResearch
Minister for Manpower and Second Minister for Trade and Industry Published by and at the direction of Tan See Leng. Blk 46 Marine Crescent #01- 42 Singapore 440046
I joined the A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) to celebrate their 40th Anniversary Gala Dinner last evening. As Singapore’s first life sciences research institute, IMCB has played a pivotal role in our biomedical journey as we grew to become a key node in the global biomedical value chain. In today’s uncertain and complex global environment, it is even more important for us to strengthen Singapore’s value proposition. A core part of this lies in building deep research and technological capabilities. A*STAR, including IMCB, will have a vital role to play in this effort. As IMCB charts its course forward, they will focus on emerging biomedical areas for impact while nurturing a vibrant scientific pool. To this end, I am glad to witness the launch of the IMCB Alumni Chapter — an important step in bringing together IMCB’s scientific community to collaborate, grow, and inspire the next generation. Congratulations IMCB on 40 remarkable years. Here's to many more decades of scientific excellence and innovation!